$0.3088
-0.00985-3.09%
Ult. Agg.: Oct 13, 10:24 AM
Senti Biosciences (SNTI) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.28 | $-0.34 | $-0.46 | $-0.58 |
| Actual | $-0.41 | $-0.14 | $-0.53 | $-0.69 |
| Surprise | -46.4% | +58.8% | -15.2% | -19.0% |
| Revenue | ||||
| Estimate | — | — | $500000 | $166670 |
| Actual | $17000 | $16000 | $22000 | $0 |
| Surprise | — | — | -95.6% | -100.0% |
| Metric | Q3 '26E | Q4 '26E |
|---|---|---|
| Earnings Per Share (Non-GAAP) | ||
| Consensus | $-0.31 | $-0.35 |
| Revenue | ||
| Consensus | — | — |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Aug 14, 2026 | $-0.41 | $-0.28 | -46.4 % |
| Q1 | May 14, 2026 | $-0.14 | $-0.34 | 58.8 % |
| Q4 | Mar 27, 2026 | $-0.53 | $-0.46 | -15.2 % |
| Q3 | Nov 13, 2025 | $-0.69 | $-0.58 | -19.0 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q4 | Mar 27, 2026 | $22.00K | $500.00K | -95.6 % |
| Q3 | Nov 13, 2025 | $0 | $166.67K | -100.0 % |
| Q2 | Aug 7, 2025 | $0 | $250.00K | -100.0 % |
| Q4 | Mar 20, 2025 | $0 | $2.80M | -100.0 % |